CSIMarket Company Name, Ticker, Suppliers, else..
 
Calliditas Therapeutics Ab  (NASDAQ: CALT)
 

Calliditas Therapeutics Ab's Suppliers Performance

CALT's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
CALT Costs vs Sales of Suppliers Growth

• More on CALT Suppliers






Calliditas Therapeutics Ab's Comment on Supply Chain


The company utilizes third-party contract manufacturers for raw materials and product manufacturing, which are required to comply with FDA current Good Manufacturing Practice (cGMP) regulations and comparable foreign regulatory standards. These manufacturers undergo unannounced inspections to verify compliance. Noncompliance by these manufacturers may result in product liability claims, recalls, regulatory sanctions, and delays in product development or commercialization. The pool of manufacturers qualified and willing to operate under cGMP regulations is limited. Increased demand due to health epidemics or pandemics may further constrain manufacturing capacity. Any interruption or termination of services by these manufacturers could lead to delays and financial impacts while alternative manufacturers are identified.

Calliditas Therapeutics Ab's Comment on Supply Chain


The company utilizes third-party contract manufacturers for raw materials and product manufacturing, which are required to comply with FDA current Good Manufacturing Practice (cGMP) regulations and comparable foreign regulatory standards. These manufacturers undergo unannounced inspections to verify compliance. Noncompliance by these manufacturers may result in product liability claims, recalls, regulatory sanctions, and delays in product development or commercialization. The pool of manufacturers qualified and willing to operate under cGMP regulations is limited. Increased demand due to health epidemics or pandemics may further constrain manufacturing capacity. Any interruption or termination of services by these manufacturers could lead to delays and financial impacts while alternative manufacturers are identified.







CALT's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Calliditas Therapeutics Ab 1,073.44 129.24 -50.11 85
SUBTOTAL 0.00 0.00 0.00 -


Sources: Calliditas Therapeutics Ab's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Calliditas Therapeutics Ab’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.